In a groundbreaking study, researchers combined mRNA vaccines with immunotherapy to combat melanoma, a deadly skin cancer. Conducted over two and a half years, the trial included 157 mid-stage melanoma patients in a collaborative effort between Moderna and Merck. The results, recently published, reveal a significant increase in survival rates among participants. Keytruda, the immunotherapy […]
